FI915715A0 - Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliini-amiinien valmistamiseksi - Google Patents
Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliini-amiinien valmistamiseksiInfo
- Publication number
- FI915715A0 FI915715A0 FI915715A FI915715A FI915715A0 FI 915715 A0 FI915715 A0 FI 915715A0 FI 915715 A FI915715 A FI 915715A FI 915715 A FI915715 A FI 915715A FI 915715 A0 FI915715 A0 FI 915715A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- pharmacologically active
- compounds
- alkyl
- tricyclic fused
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36437489A | 1989-06-09 | 1989-06-09 | |
US36437489 | 1989-06-09 | ||
US9002621 | 1990-05-15 | ||
PCT/US1990/002621 WO1990015058A1 (en) | 1989-06-09 | 1990-05-15 | Heterocyclic amines having central nervous system activity |
Publications (3)
Publication Number | Publication Date |
---|---|
FI915715A0 true FI915715A0 (fi) | 1991-12-04 |
FI96310B FI96310B (fi) | 1996-02-29 |
FI96310C FI96310C (fi) | 1996-06-10 |
Family
ID=23434241
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI915715A FI96310C (fi) | 1989-06-09 | 1991-12-04 | Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliini-amiinien valmistamiseksi |
FI944704A FI96687C (fi) | 1989-06-09 | 1994-10-07 | Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliiniamiinien valmistamiseksi |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944704A FI96687C (fi) | 1989-06-09 | 1994-10-07 | Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliiniamiinien valmistamiseksi |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0480939B1 (fi) |
JP (1) | JP2955358B2 (fi) |
KR (1) | KR0167346B1 (fi) |
AT (1) | ATE117688T1 (fi) |
AU (1) | AU626427B2 (fi) |
CA (1) | CA2051697C (fi) |
DE (1) | DE69016430T2 (fi) |
DK (1) | DK0480939T3 (fi) |
ES (1) | ES2067744T3 (fi) |
FI (2) | FI96310C (fi) |
HK (1) | HK65397A (fi) |
HU (2) | HU210264B (fi) |
NO (1) | NO301421B1 (fi) |
RU (1) | RU2023712C1 (fi) |
WO (1) | WO1990015058A1 (fi) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05117276A (ja) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な3環性キノキサリンジオン誘導体 |
TW260660B (fi) * | 1993-04-22 | 1995-10-21 | Sumitomo Pharma | |
DE4314593A1 (de) * | 1993-04-28 | 1994-11-03 | Schering Ag | Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln |
AU684808B2 (en) * | 1993-07-27 | 1998-01-08 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
FR2719843B1 (fr) * | 1994-05-10 | 1996-06-07 | Synthelabo | Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique. |
EP0705834A1 (de) * | 1994-07-27 | 1996-04-10 | Ciba-Geigy Ag | Azaaliphatisch Überbrückte Chinoxalin-2,3-dione |
EP0705835A1 (de) * | 1994-09-01 | 1996-04-10 | Ciba-Geigy Ag | Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione |
CN1198163A (zh) * | 1995-08-10 | 1998-11-04 | 拜尔公司 | 卤代苯并咪唑 |
US6288075B1 (en) | 1998-02-26 | 2001-09-11 | Rhone-Poulenc Rorer S.A. | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same |
FR2760237B1 (fr) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
BR0007871A (pt) | 1999-02-05 | 2001-10-16 | Upjohn Co | Processo para preparar (5r)-(metilamino)-5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h) ona |
US7074927B2 (en) | 1999-05-13 | 2006-07-11 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
DE19954707A1 (de) | 1999-11-13 | 2001-05-17 | Merck Patent Gmbh | Imidazolverbindungen als Phosphodiesterase VII-Hemmer |
GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
NZ531172A (en) * | 2000-04-21 | 2005-07-29 | Upjohn Co | Heterocyclic amine-type compounds for treating fibromyalgia and chronic fatigue syndrome |
AR033520A1 (es) * | 2000-04-27 | 2003-12-26 | Upjohn Co | (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona |
WO2002013807A2 (en) | 2000-08-16 | 2002-02-21 | Pharmacia & Upjohn Company | Compounds for the treatment of addictive disorders |
AR031200A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados |
AR031202A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados |
AR031199A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados |
FR2825705B1 (fr) | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
TW200307682A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
TWI312781B (en) | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
AR040680A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Composicion de tabletas de liberacion sostenida |
US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
US20050079217A1 (en) * | 2002-07-25 | 2005-04-14 | Ganorkar Loksidh D. | Sustained-release tablet composition comprising a dopamine receptor agonist |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
KR20050057671A (ko) * | 2002-10-25 | 2005-06-16 | 파마시아 앤드 업존 캄파니 엘엘씨 | 신경보호제로서의 헤테로시클릭 아민-타입 화합물의 용도 |
CN100471856C (zh) * | 2003-07-31 | 2009-03-25 | Irm责任有限公司 | 作为pdf抑制剂的二环化合物和组合物 |
WO2005051488A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Combination of dopamine agonists and monoamine reuptake inhibitors |
KR101406767B1 (ko) | 2004-08-13 | 2014-06-20 | 베링거 인겔하임 인터내셔날 게엠베하 | 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출성 정제 제형, 이의 제조방법 및 이의용도 |
EP2431027A1 (en) | 2004-08-13 | 2012-03-21 | Boehringer Ingelheim International GmbH | Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR052227A1 (es) * | 2004-11-05 | 2007-03-07 | Wyeth Corp | Metabolitos derivados de [1,4] diazepin [ 6,7,1-ij] quinolina, metodos de preparacion y usos de los mismos |
WO2006138195A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Macrocyclic heterocyclic aspartyl protease inhibitors |
AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
EP2895485A1 (en) | 2012-09-14 | 2015-07-22 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
US20140080813A1 (en) | 2012-09-14 | 2014-03-20 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3563389A (en) * | 1988-05-09 | 1989-11-29 | Upjohn Company, The | Anxiolytic/anti-depressant 2,3-dihydro-1h-phenalen-2-amines |
-
1990
- 1990-05-15 AU AU57438/90A patent/AU626427B2/en not_active Ceased
- 1990-05-15 DE DE69016430T patent/DE69016430T2/de not_active Expired - Fee Related
- 1990-05-15 JP JP2508489A patent/JP2955358B2/ja not_active Expired - Fee Related
- 1990-05-15 KR KR1019910701790A patent/KR0167346B1/ko not_active IP Right Cessation
- 1990-05-15 WO PCT/US1990/002621 patent/WO1990015058A1/en active IP Right Grant
- 1990-05-15 HU HU905216A patent/HU210264B/hu not_active IP Right Cessation
- 1990-05-15 ES ES90908816T patent/ES2067744T3/es not_active Expired - Lifetime
- 1990-05-15 AT AT90908816T patent/ATE117688T1/de not_active IP Right Cessation
- 1990-05-15 CA CA002051697A patent/CA2051697C/en not_active Expired - Fee Related
- 1990-05-15 EP EP90908816A patent/EP0480939B1/en not_active Expired - Lifetime
- 1990-05-15 DK DK90908816.3T patent/DK0480939T3/da active
-
1991
- 1991-12-04 FI FI915715A patent/FI96310C/fi active
- 1991-12-06 NO NO914827A patent/NO301421B1/no unknown
- 1991-12-06 RU SU915010471A patent/RU2023712C1/ru not_active IP Right Cessation
-
1994
- 1994-10-07 FI FI944704A patent/FI96687C/fi active
-
1995
- 1995-06-30 HU HU95P/P00660P patent/HU211702A9/hu unknown
-
1997
- 1997-05-15 HK HK65397A patent/HK65397A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FI96687B (fi) | 1996-04-30 |
CA2051697A1 (en) | 1990-12-10 |
NO301421B1 (no) | 1997-10-27 |
FI96687C (fi) | 1996-08-12 |
WO1990015058A1 (en) | 1990-12-13 |
ES2067744T3 (es) | 1995-04-01 |
AU626427B2 (en) | 1992-07-30 |
HU211702A9 (en) | 1995-12-28 |
FI944704A0 (fi) | 1994-10-07 |
KR0167346B1 (ko) | 1999-01-15 |
FI96310B (fi) | 1996-02-29 |
ATE117688T1 (de) | 1995-02-15 |
EP0480939B1 (en) | 1995-01-25 |
JP2955358B2 (ja) | 1999-10-04 |
DE69016430T2 (de) | 1995-06-01 |
HU210264B (en) | 1995-03-28 |
DE69016430D1 (de) | 1995-03-09 |
FI944704A (fi) | 1994-10-07 |
AU5743890A (en) | 1991-01-07 |
NO914827L (no) | 1992-02-07 |
JPH04506071A (ja) | 1992-10-22 |
HK65397A (en) | 1997-05-23 |
EP0480939A1 (en) | 1992-04-22 |
FI96310C (fi) | 1996-06-10 |
DK0480939T3 (da) | 1995-07-10 |
KR920701204A (ko) | 1992-08-11 |
HUT60269A (en) | 1992-08-28 |
CA2051697C (en) | 1996-10-08 |
HU905216D0 (en) | 1992-02-28 |
RU2023712C1 (ru) | 1994-11-30 |
NO914827D0 (no) | 1991-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI915715A0 (fi) | Menetelmä farmakologisesti aktiivisten trisyklisesti kondensoituneiden kinoliini-amiinien valmistamiseksi | |
FI102175B (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten v almistamiseksi | |
BG104187A (en) | 4-phenyl-pyridine derivatives | |
HK50996A (en) | Treatment of gastrointestinal disorders using 5-ht3 antagonists | |
GEP20053475B (en) | Arylmethyl-Carbonylamino-Thiazole Derivatives, and Their Use as Antitumor Agents | |
KR970703333A (ko) | 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists) | |
ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
IT1255178B (it) | N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica | |
ATE101040T1 (de) | Derivate und analoge von pyrimidon zur behandlung von asthma und bestimmte hautkrankheiten. | |
YU46706B (sh) | Postupak za dobijanje amidnih jedinjenja | |
EP0337136A3 (en) | Piperidine derivatives in the treatment of extrapyramidal side effects associated with neuroleptic therapy | |
KR900012893A (ko) | 치환된-아세트 아미드 화합물 및 그 제조방법 | |
KR920701122A (ko) | 신규 이환식 아미노-치환 화합물 | |
AR036131A1 (es) | Derivados de benzo (g) quinolina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la fabricacion de un medicamento | |
PT1082116E (pt) | Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento | |
ES8101045A1 (es) | Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos | |
DE69327077T2 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
KR910700236A (ko) | 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도 | |
PT85429A (en) | Process for the preparation of pharmaceutical compositions | |
DE69010606D1 (de) | 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
TC | Name/ company changed in patent |
Owner name: PHARMACIA & UPJOHN COMPANY |